Symphony Technology Group acquires divisions of United BioSource Corporation
Client(s) Symphony Technology Group LLC
Jones Day advised Symphony Technology Group LLC, a technology and services-focused private equity firm, in connection with its acquisition of the health economics, health outcomes, market access and retrospective epidemiology and data analytics divisions of United BioSource Corporation, a wholly owned subsidiary of Express Scripts Holding Company. Jones Day acted as special Texas legal counsel.